Home > PORTAL > about Us > Presentation >
Discover the services provided by SPIN’s website
How does www.spindermatology.org work?
The SPIN website offers you several services:
>> World Directory of Psoriasis Medial Resources
An interactive map listing dermatology centres specialised in the management of psoriasis. For each centre listed in this directory, you can see which medical resources they provide to psoriasis patients: available treatments, dedicated inpatient/outpatient facilities, interdisciplinary consultations, clinical trials, collaboration with patient associations.
For each centre, you can learn how to get an appointment, and you have access to the postal address and contact information.
>> World Directory of Atopic Dermatitis Medial Resources (coming soon!)
>> PIN News
Each member of the network can contribute with articles, events, works, etc., as long as the documents are provided in English. In this section, you will find:
- Our "Focus On" on major works or events of the network or special showcases of our partner medical groups or patient associations; also, you will find the latest news published in our website
- The news from the weboffice provides general information on SPIN activities
- In the events tab you will find a list of national and international events such as conferences, meetings, World Psoriasis Day...
- The news from medical groups showcasing the works shared by the national groups
- The news from patient associations presenting the latest activities of our partner associations
- The recent publications on psoriasis lists the latest Pumed articles on psoriasis and atopic dermatitis
When you wish to share information with the SPIN community, please send it in English to our weboffice. We will then post your news in the news section.
>> Running Projects
In this section you will find all the relevant information about SPIN’s ongoing projects and activities.
>> The Country Sites section
This section fosters the websites of national medical groups and of patient associations. Also, it allows those groups or associations that don’t have a website of their own, to create one for free. To proceed to the creation of your own website, please visit the "Country Sites" section and follow the instructions.
The national websites give you general information about the countries which are part of the network and it aims at:
- Fostering connections in each country between dermatologists and patients,
- Making easier to share information and to engage collaborations between countries.
To design and manage your own website, please use the website management tool.
>> The Website Management Tool
The website management tool is designed for your national medical group or for your patient association. This tool will guide you to build a website in your national language or to create a link with your pre-existent website. To use this section, you need to register. Please go to the website management tool at the bottom right of the homepage.
If you have any question, please, do no hesitate to contact our weboffice.
>> The International Links section
This section provides you links to other international psoriasis and atopic dermatitis organisations.
>> The Keywords section
This section gives you general information about psoriasis. It is a glossary with direct links to Pubmed’s main publications on psoriasis. A similar glossary for atopic dermatitis is to be developed soon.
SPIN Presentation
Recent news
- 2019/10/29 Focus on...
- 2019/08/12 Focus on...
Latin American Clinical Practice Guidelines on the Systemic Treatment of Psoriasis
- 2019/06/03 Focus on...
- 2019/05/21 Focus on...
Prof Nelida Aurora Raimondo
News from the web office
- 2016/10/29
- 2016/05/26
- 2016/02/20
Events
- 2019/04/18 Focus on...
- 2018/02/21
News from medical groups
- 2018/04/18
- 2017/06/21
News from patients associations
- 2017/02/08
- 2016/05/26
Recent publications on Psoriasis and Atopic Dermatitis
on Psoriasis
Discovery of benzo[f]pyrido[4,3-b][1,4]oxazepin-10-one derivatives as orally available bromodomain and extra-terminal domain (BET) inhibitors with efficacy in an in vivo psoriatic animal model.
Bioorg Med Chem.
2021 Mar 15, 34:116015.
Bromodomain and extra-terminal domain (BET) protein plays an important role in epigenetic regulation, and the regulation of disruption contributes to the pathogenesis of cancer and inflammatory disease. With the goal of discovering novel BET inhibitors, especially BRD4 inhibitors, we designed and synthesized several compounds starting from our previously reported pyrido-benzodiazepinone derivative 4 to enhance BRD4 inhibitory activity while avoiding hERG inhibition. Molecular docking (...)
see on pubmed
Clinical trait-connected network analysis reveals transcriptional markers of active psoriasis treatment with Liangxue-Jiedu decoction.
J Ethnopharmacol.
2021 Mar 25, 268:113551.
Psoriasis is a complex recurrent inflammatory skin disease with different pathological changes in different stages. Psoriasis in its active stage, which is comparable to the blood-heat type in traditional Chinese medicine (TCM), has been treated by Liangxue Jiedu Decoction (LJD) in TCM for decades, with proven efficacy. According to TCM theories, LJD has the function of removing heat and pathogenic factors from the (...)
see on pubmed
Catalpol ameliorates psoriasis-like phenotypes via SIRT1 mediated suppression of NF-κB and MAPKs signaling pathways.
Bioengineered.
2021 Dec , 12, (1):183-195.
Psoriasis is a chronic inflammatory skin disease that affects approximately 2% of worldwide population, and causing long-term troubles to the patients. Therefore, it is urgent to develop safe and effective therapeutic drugs. Catalpol is a natural iridoid glucoside, that has several remarkable pharmacological effects, however, whether catalpol can alleviated psoriasis has not been explored. The goal of the present work is to study the role of catalpol in psoriasis in vivo and in vitro. (...)
see on pubmed
on Atopic Dermatitis
Psychiatric and Nonpsychiatric Comorbidities Among Children With ADHD: An Exploratory Analysis of Nationwide Claims Data in Germany.
J Atten Disord.
2021 Apr , 25, (6):874-884.
This study examined the full spectrum of comorbid disorders in all statutory-health-insured children aged 5 to 14 years with ADHD in 2017 by using nationwide claims data in Germany. Children with ADHD ( = 258,662) were compared for the presence of 864 comorbid diseases with a control group matched by gender, age, and region of residence ( = 2,327,958). Among others, metabolic disorders (odds ratio [OR] = 9.18; 95% confidence interval [CI] = [8.43, 9.99]), viral pneumonia (OR = 4.95; 95% (...)
see on pubmed
Qingxue jiedu formulation ameliorated DNFB-induced atopic dermatitis by inhibiting STAT3/MAPK/NF-κB signaling pathways.
J Ethnopharmacol.
2021 Apr 24, 270:113773.
Qingxue jiedu Formulation (QF) is composed of two classic prescriptions which have been clinically used for more than 5 centuries and appropriately modified through basic theory of traditional Chinese medicine for treating various skin inflammation such as atopic dermatitis (AD), acute dermatitis and rash. Although QF possesses a prominent clinical therapeutic effect, seldom pharmacological studies on its anti-AD activity are (...)
see on pubmed
Methicillin-resistant from infected skin lesions present several virulence genes and are associated with the CC30 in Brazilian children with atopic dermatitis.
Virulence.
2021 Dec , 12, (1):260-269.
Atopic dermatitis (AD) is a chronic inflammatory skin disease and colonization by may affect up to 100% of these patients. Virulent and resistant isolates can worsen AD patient clinical condition and jeopardize the treatment. We aimed to detect virulence genes and to evaluate the biofilm production of isolates from infected skin lesions of children with AD. Methicillin resistance was detected by phenotypic and molecular tests and the virulence genes were detected by PCR. Biofilm formation (...)
see on pubmed
